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Abstract
Background: Low serum vitamin D [25(OH)D] has been associated with different health problems worldwide.
However, its causal role in several diseases remains unclear. We aimed to correlate vitamin D status with maternal
and neonatal outcomes in pregnant females.
Method: One thousand pregnant women were recruited during early labour from the labour ward of King Khaled
University Hospital, Riyadh, Saudi Arabia. Detailed medical data of all participants were collected from their records.
Delivery events and birth outcomes were also documented. Serum 25(OH)D levels were measured using an
enzyme-linked immunosorbent assay. A receiver operating characteristic (ROC) curve was constructed to evaluate
the ability of vitamin D levels to predict complicated pregnancies. Regression analysis was used to test the
correlation between serum 25(OH)D levels and different variables.
Results: Most of the participants were Saudis (89.9 %) and housewives (85.1 %) and 86.4 % of them had vitamin D
deficiency (mean: 30.46 ± 19.6 nmol/L). Gestational diabetes mellitus (GDM) was the commonest complication
detected (11.1 %) while the history of miscarriage was elevated (24.5 %). There was no association between GDM
and low 25(OH)D. Yet, there was a significant negative correlation between serum 25(OH)D levels and fasting blood
glucose among females older than 35 years (r = −0.2, p = 0.03). Hypertensive disorders of pregnancy and
pre-existing hypertension were less than 1.5 % of frequency. Nevertheless, they were only recorded in women with
insufficient and deficient vitamin D. ROC curve revealed that 25(OH)D levels were not able to discriminate between
normal and adverse pregnancy outcomes (AUROC curve: 0.51; 95 % confidence interval (CI): 0.44–0.58; p = 0.8).
Conclusion: Hypovitaminosis D, a highly prevalent health problem among pregnant females in Riyadh, has no
relation to adverse pregnancy outcomes except for a higher prevalence of miscarriage in women with low
25(OH)D.
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Background
Vitamin D, also known as calciferol, is a prohormone
that plays an important role in calcium homeostasis and
bone health in addition to its neuromuscular functions
[1]. Vitamin D has two major forms, vitamin D2 and
vitamin D3. They are further metabolized into 25-
hydroxyvitamin D (25(OH)D) and 1,25- dihydroxy
vitamin D (1,25(OH)2D), the active form of vitamin
D, in the liver and the kidney, respectively [2, 3].
25(OH)D is the main circulating vitamin D metab-
olite and its serum level serves as a biomarker of
the vitamin status [4].
Beyond its effect on bone homeostasis, 25(OH)D has
been implicated in varying clinical conditions. In the last
two decades, the non-classical function of vitamin D has
been suggested; it regulates a large number of human
genes (~200 genes), resulting in a wide range of auto-
crine effects in different tissues [5]. For example, vitamin
D is involved in regulation of cell proliferation, cell
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differentiation, and apoptosis [4]. In addition, it exerts
immune responses through regulation of the innate and
adaptive immunity [6]. This explains the correlation of
hypovitaminosis D to the potential risk of a series of
conditions like hypertension, diabetes mellitus, cancer,
multiple sclerosis, allergy, asthma, autoimmune and in-
fectious diseases as well as depression [7, 8].
In Saudi Arabia, hypovitaminosis D can be considered a
major public health problem with a significantly high
prevalence especially among women, ranging from to ~80
to 100 % in different studies [9–11]. Vitamin D deficiency
can be seen not only in infancy and childhood but also
across the other life stages from adolescence, adulthood,
until old age [12]. The risk of vitamin D deficiency in-
creases during pregnancy due to the increase in maternal
and fetal demands [13]. Moreover, vitamin D is postulated
to have a potential effect on several pregnancy outcomes
including fetal skeletal outcome, hypertensive disorders,
and gestational diabetes mellitus (GDM) [14–16]. To our
knowledge, there is no published data on the relation of
low vitamin D and pregnancy, or fetal development, in the
Saudi population. The current study aimed to assess
25(OH)D levels in pregnant females residing in Riyadh,
and to correlate the vitamin status to the possible mater-
nal and neonatal adverse outcomes.
Methods
This is a cross-sectional study where all consecutive
pregnant females admitted in labour ward were invited
to join the study. The study was conducted in accord-
ance with the guidelines of the Declaration of Helsinki
and was approved by the Institutional Review Board
(IRB) of King Saud University. All pertinent study infor-
mation was explained to all participants and they were
informed that rejection or withdrawal from the study
will not affect any medical service provided. A summa-
rized study information sheet was shown to all cases
before obtaining their verbal agreement. Finally, an in-
formed verbal consent was obtained and witnessed by
the attending nurse. A log book was created including
the participant’s study number and the date of consent.
The IRB waived the requirement for taking a written
consent as the research had minimal risk of harm to
subjects and involved no risky procedures for which
written consent is required. The study was adherent to
the STROBE criteria as outlined in Additional file 1.
Inclusion and exclusion criteria
Recruitment of 1000 consecutive women was accom-
plished in the labour ward in King Khaled University
Hospital (KKUH), Riyadh, Saudi Arabia, between the be-
ginning of January till the end of June 2014. Exclusion
criteria included known chronic illnesses [except hyper-
tension and diabetes mellitus], metabolic bone disease,
intestinal malabsorption, any evidence of liver, kidney, or
gastrointestinal diseases), and the use of vitamin D sup-
plements and/or other medications that affect vitamin D
level (e.g. anticonvulsants, antituberculosis drugs).
Data collection
Data on socio-demographics, medical and reproductive
history were collected from all subjects. Medical records
were abstracted to ascertain their anthropomorphic
characteristics as well as their medical status throughout
gestation. Participants’ pre-pregnancy body weights were
not available in the record; pregnancy body mass index
(BMI) was calculated using the admission weight and
height measurements. All participants were screened for
GDM by estimation of 75-g oral glucose tolerance test
(OGTT) between 24 and 28 weeks of gestation. Data of
OGTT and adverse pregnancy outcomes (e.g. GDM, ges-
tational hypertension, preeclampsia and intrauterine
growth restriction based on two measurements, at least,
2 weeks apart) were retrieved from their files. Diagnosis
of preeclampsia was based on the new onset of hyperten-
sion (systolic blood pressure ≥140 mm Hg or diastolic
blood pressure ≥90 mm Hg) after 20 weeks gestation in
addition to proteinuria (≥300 mg/24 h). Gestational hyper-
tension was defined as De novo hypertension alone, occur-
ring after 20 weeks gestation in a previously normotensive
woman [17]. Delivery events (e.g. preterm delivery, caesar-
ean section) and birth outcomes (e.g. anthropometric
birth outcomes, APGAR score and neonatal admission to
the ICU) were recorded after labour.
Estimation of serum 25(OH)D level
Blood samples were collected for vitamin D estimation,
and sera were processed and stored at −80 °C until ana-
lyzed. Quantification of serum 25(OH)D was performed
using a commercial enzyme-linked immunosorbent assay
(ELISA) (K2110, Immunodiagnostic [Dutch Company],
Holland). The range of detection was 5–300 nmol/L.
Patients’ vitamin D status was evaluated according to the
25(OH)D concentrations into deficient [Levels below
50 nmol/L (20 ng/ml)], insufficient [concentrations be-
tween 51 and 74 nmol/L (21–29 ng/ml)] and normal
[25(OH)D ≥75 nmol/L (≥30 ng/ml)] [18, 19].
Statistical analysis
Sample size calculation was based on previous literature
findings, where ~ 83 % of GDM patients suffered from
vitamin D deficiency/insufficiency compared to 71 % in
non-GDM subjects [20]. Assuming a significance level of
95 % (α = 0.05) and a power of 80 % (β = 0.20), calcula-
tion of the sample size revealed that the minimum num-
ber of participants required to reject the null hypothesis
was 900. Statistical analysis was performed using the
SPSS software v.20.0 for Windows® (SPSS Inc., Chicago,
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IL, USA). Data were presented as mean ± SD and per-
centages. Univariate analysis and differences between
groups were assessed using the Student’s t-test, or
Chi-square (χ2) test when appropriate. Receiver oper-
ating characteristic (ROC) curve was constructed and
the area under the curve (AUC) was calculated to
evaluate the specificity and sensitivity of vitamin D
levels to predict complicated pregnancies from normal
ones. Pearson correlation coefficient was used to test
the correlation between quantitative variables. Linear
regression statistics were used to determine the rela-
tionship between fasting OGTT and serum 25(OH)D
levels with adjustment for age, BMI and parity. In
addition, logistic regression analysis was adopted to
assess the correlation between the history of miscar-
riage and the vitamin D levels adjusted for age and
BMI. The values of 25(OH)D were log-transformed to
achieve normality. All statistical tests were two-tailed, and
a p-value <0.05 was considered statistically significant.
Results
The age of women included in the study ranged from 17
to 47 years and ~ half of them were between 25 and
35 years. Most of the participants were Saudis (89.9 %)
and housewives (85.1 %). Table 1 shows the socio-
demographic data, reproductive information and out-
comes of the current pregnancy in the studied population.
The major form of pregnancy-associated complications
was GDM (11.1 %), followed by intrauterine growth re-
striction and gestational hypertension (1.5 and 1.4 %, re-
spectively) and the least one was preeclampsia (0.9 %).
Out of the 19 patients (1.9 %) who had pre-gestational dia-
betes 14 had type-1 diabetes mellitus (1.4 %) and five had
type-2 (0.5 %). Surprisingly, history of miscarriage among
pregnant females was highly elevated (24.5 %). According
to the pregnancy BMI, 56.7 % of the women were
higher than 30 kg/m2, while 31 % ranged between 25
and 30 kg/m2 and 12.3 % was below 25 kg/m2.
Serum 25(OH)D levels ranged from 7.1 to 150 nmol/L.
Division of the participants according to their vitamin D
status revealed that the majority of women had vitamin D
deficiency (86.4 %; mean: 24.2 ± 10.6 nmol/L; range:
7.1–49.9). Table 2 shows a comparison between study
participants’ data, pregnancy and birth outcomes in
relation to their vitamin D status. Women with defi-
ciency were mostly in the middle age group [25–35
years] and they were housewives (p < 0.01 and = 0.02,
respectively). There was no difference in the GDM
frequencies in vitamin D status subgroups. Moreover,
there was a significant increase in the percentage of
women with positive history of miscarriage in the in-
sufficient status compared to the deficient and normal
ones (p = 0.02) (Table 2). On the other hand, gestational
hypertension, pre-existing hypertension, preeclampsia and
pre-existing diabetes mellitus were only recorded in
women with deficient and insufficient vitamin D. How-
ever, these frequencies did not reach significant levels
(Table 2). Furthermore, there was no difference between
women with low vitamin D and those with normal vita-
min status regarding birth outcomes (p > 0.05).
Seventy-four percent of women had a normal preg-
nancy, delivery and neonatal outcomes. This sub-group
of participants had a mean vitamin D level of 29.6 ±
18.9 nmol/L (range: 7.5–101). A ROC curve was plotted
to investigate the potential ability of serum 25(OH)D to
identify normal pregnancy outcomes (Fig. 1). Vitamin D
levels were not able to discriminate between normal
pregnancies and birth outcomes and any possible com-
plication (AUROC curve: 0.51; 95 % confidence interval
(CI): 0.44–0.58; p = 0.8). A noticed significant age dis-
crepancy was confirmed between vitamin D subgroups.
As there might be a co-linearity between age and parity,
a stratified analysis of the correlation between 25(OH)D
and parity among different age groups was conducted. A
weak negative correlation between vitamin D levels and
parity was apparent, especially in older age groups
(>35 years) (r = −0.07, p = 0.3) (Fig. 2a). On the other
hand, a significant negative correlation was evident
between the levels of 25(OH)D and those of fasting
OGTT among the oldest age group (>35 years) (r = −0.2,
p = 0.03) (Fig. 2b). Adjustment for age, BMI and parity via
linear regression model revealed a weak negative relation-
ship between serum 25(OH)D and fasting OGGT levels;
however, this did not reach statistical significance
(β = −0.07, adjusted r2 = 0.04, p = 0.16). Moreover, lo-
gistic regression analysis showed that women with
higher levels of vitamin D were less likely to report
the history of miscarriage (odds ratio 0.7, 95 % confidence
interval: 0.35–1.45, p = 0.3); yet, this correlation was not
statistically significant.
Discussion
The presence of vitamin D receptors (VDR) in almost
every tissue drew the attention to the identification of
the extra-skeletal functions of vitamin D [21]. So far,
thousands of research have been published to explore
the implication of vitamin D in human illness. It has also
been correlated to maternal and fetal health during preg-
nancy [22]. Despite abundant sunlight, hypovitaminosis
D is highly prevalent among the Saudi population. It is
more frequent in the young and middle-aged group of
apparently healthy Saudi adults [23] and in females more
than males [10]. A limited number of publications in
Saudi Arabia studied vitamin D deficiency in relation to
diseases beyond bone health, e.g. diabetes mellitus
[23, 24] and obesity [25]. Al-Mogbel [9] investigated
vitamin D levels in Saudi females in the childbearing period
and reported that all participants had hypovitaminosis D
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and the majority had a severe form of deficiency (~79 %).
In spite of this high figure, no study has been published in
the kingdom of Saudi Arabia about the effect of vitamin D
deficiency on maternal and birth outcomes.
The current study revealed that vitamin D deficiency
was highly prevalent, mostly in the middle-aged preg-
nant women. Overall, vitamin D status had no relation
to the risk of adverse pregnancy and neonatal outcomes.
25(OH)D concentrations showed no association with the
risk of GDM while hypertensive disorders of pregnancy
existed only in women with insufficient and deficient
vitamin D. In addition, positive history of miscar-
riage was highly elevated in women with vitamin D
insufficiency.
GDM was the most common maternal complication
in this study. Its prevalence was consistent with that re-
ported globally (4.1–27.5 %) [26]. Previous reports asso-
ciated vitamin D deficiency with GDM [27, 28] and in
several countries like Iran [29], Australia [30] and the
United States [16]. On the contrary and similar to our
results, no significant association was reported by Rodri-
guez et al. [31] and Flood-Nichols et al. [32] and in dif-
ferent countries too, e.g. India [33], the United Kingdom
[34] and the United States [35]. It should be noted that
vitamin D supplementation during early pregnancy de-
creased the incidence of GDM in women having vitamin
D level below 80 nmol/L, yet this frequency was not sig-
nificant when compared to the one who did [36]. On the
other hand, an association of vitamin D deficiency with
impaired insulin secretion has been observed in different
studies [37, 38]. Inadequate insulin secretion has been
identified in rodents with vitamin D deficiency [39]. In
addition, a significant correlation was described between
25(OH)D levels in pregnant women and insulin sensitiv-
ity or fasting blood glucose levels [40]. This might
explain the weak negative correlation between fasting
blood glucose and vitamin D levels in our study. A simi-
lar inverse correlation was also observed by Tsur et al.
with more potency to the progression from normogly-
cemia to hyperglycemia in patients with severe vitamin
D deficiency (levels less than 25 nmol/L) [41].
Preeclampsia, an adverse effects ranging from 2 to
17 % in pregnant women worldwide [42], has been diag-
nosed in less than 1 % of our study population. Though,
hypertensive disorders of pregnancy existed only in
Table 1 Socio-demographic and clinical data of the study
population
Age (years; mean ± SD [range]) 29.03 ± 5.7 [17–47]
Age distributiona
Less than 25 years 321 (32.2)
25–35 years 513 (51.4)
More than 35 164 (16.4)
Nationality
Saudi 899 (89.9)
Non Saudi 101 (10.1)
Educationa
High school 668 (70.4)








Positive history of multiple pregnancies 56 (5.6)
Positive history of miscarriage 245 (24.5)
Status of current pregnancy
Smoking during pregnancya 20 (0.2)
Gestational age till delivery (Weeks; mean ± SD
[range])
38.7 ± 1.9 [23–42]
Pregnancy BMI (Kg/m2; mean ± SD [range]) 30.9 ± 6.7 [14.5–55.8]
Gestational diabetes 111 (11.1)
Pre-Gestational diabetes 19 (1.9)
Pre-existing hypertension 4 (0.4)
Gestational hypertension 14 (1.4)
Preeclampsia 9 (0.9)
Intrauterine growth restriction 15 (1.5)
Delivery and neonatal outcomes
Preterm labour 80 (8.0)
Induction of labour 128 (12.8)
Mode of delivery
Spontaneous 768 (76.8)
Instrumental delivery 61 (6.1)
Caesarian Section 171 (17.1)
Baby’s weight (Kg; mean ± SD [range]) 3.1 ± 0.5 [1.06–5.3]
Baby’s length (cm; mean ± SD [range]) 49.5 ± 2.7 [34–62]
Baby’s head circumference (cm; mean ± SD
[range])
34.1 ± 1.9 [26–52]
Table 1 Socio-demographic and clinical data of the study
population (Continued)
APGAR score 8.6 ± 0.63 [7–9]
Neonatal admission to ICU 29 (2.9)
Vitamin D level (nmol/L; mean ± SD [range]) 30.46 ± 19.6 [7.1–150]
aTotal number is below one thousand due to incomplete questionnaires; data
are expressed in number (percentage) unless specified; SD Standard deviation
Al-Shaikh et al. BMC Pregnancy and Childbirth  (2016) 16:119 Page 4 of 9
pregnant women with insufficient and deficient vitamin
D. Vitamin D and sunlight may have a role in the inci-
dence of preeclampsia that is more frequent in winter
than summer [43]. Nonetheless, controversy remains
about the relationship of vitamin D deficiency with
preeclampsia [44], and on the effectiveness of vitamin
D supplementation in reducing its risk during preg-
nancy [45].
Apparently, low 25(OH)D concentrations were not as-
sociated with birth and neonatal adverse effects in our
study. Despite the paucity of research studying preg-
nancy outcomes in relation to vitamin D status, several









Less than 25 years 11 (28.9) 20 (20.4) 290 (33.6) <0.01
25–35 years 13 (34.2) 52 (53.1) 448 (52.0)
More than 35 14 (36.8) 26 (26.5) 124 (14.4)
Nationality
Saudi 32 (84.2) 85 (86.7) 782 (90.5) 0.24
Non Saudi 6 (15.8) 13 (13.3) 82 (9.5)
Education
High school 22 (61.1) 62 (65.3) 584 (71.4) 0.32
University or higher 14 (38.9) 33 (34.7) 234 (28.6)
Working status
Housewife 28 (73.7) 78 (79.6) 745 (86.4) 0.02
Employee 10 (26.3) 20 (20.4) 117 (13.6)
Reproductive history
Parity
Primiparous 12 (31.6) 24 (24.5) 287 (32.2) 0.22
Multiparous 26 (68.4) 74 (75.5) 577 (66.8)
Positive history of miscarriage 7 (18.4) 35 (35.7) 203 (23.5) 0.02
Status of current pregnancy
Pregnancy BMI (Kg/m2; mean ± SD) 30.7 ± 5.5 30.7 ± 6.2 31.1 ± 6.9 0.66
Gestational diabetes 5 (13.5) 12 (13.3) 94 (12.0) 0.8
Pre-Gestational Diabetes 0 (0.0) 1 (1.1) 18 (2.3) 0.9
Pre-existing hypertension 0 (0.0) 1 (1.0) 3 (0.3) 0.44
Gestational hypertension 0 (0.0) 2 (2.0) 12 (1.4) 0.79
Preeclampsia 0 (0.0) 0 (0.0) 9 (1.0) 0.28
Intrauterine growth restriction 2 (5.3) 2 (2.1) 11 (1.3) 0.07
Delivery and neonatal outcomes
Preterm labour 4 (10.8) 3 (3.1) 73 (8.5) 0.14
Mode of Delivery
Spontaneous 29 (76.3) 76 (77.6) 663 (76.7)
Instrumental delivery 1 (2.6) 4 (4.1) 56 (6.5) 0.71
Caesarian section 8 (21.1) 18 (18.4) 145 (16.8)
Birth weight (Kg; mean ± SD) 3.1 ± 0.5 3.2 ± 0.4 3.1 ± 0.5 0.67
Baby’s length (cm; mean ± SD) 49.5 ± 2.2 49.7 ± 2.2 49.5 ± 2.8 0.96
Head Circumference (cm; mean ± SD) 34.1 ± 1.1 34.4 ± 1.7 34.1 ± 2.2 0.6
APGAR score (mean ± SD) 8.3 ± 1.9 8.9 ± 0.3 8.8 ± 0.8 0.05
Neonatal admission to ICU 1 (2.6) 0 (0.0) 28 (3.3) 0.18
Data are expressed in number (percentage) unless specified; SD Standard deviation
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studies recorded findings similar to our results [31, 46,
47]. However, the high frequency of history of miscar-
riage identified in this research was associated mainly
with vitamin D insufficiency. Previous studies attempted
to examine the role of low vitamin D in complications
like preterm delivery or infertility with no records on its
relation to miscarriage. The high rate of history of
miscarriage detected herein might be related to the
proposed regulatory role of vitamin D ingenes associ-
ated with placental invasion, normal implantation,
and angiogenesis [48]. In addition, vitamin D may
play a potential role in the prevention of miscarriage
due to its combined immunomodulatory and anti-
inflammatory properties during early pregnancy [49].
Another factor is the high association of vitamin D
deficiency with infectious diseases, specifically with
bacterial vaginosis [50]. Whatever their types or sites,
these infections represent a major risk to the mater-
nal health and might lead to serious pregnancy ad-
verse outcomes.
Pregnancy is a special condition during which the
body experiences several physiological alterations, in-
cluding changes in vitamin D metabolism. The effect of
vitamin D deficiency on maternal and neonatal health is
still under investigations. The controversy between the
results of documented studies did not give obvious clues
to the real association of hypovitaminosis D with mater-
nal and neonatal complications [51]. So far, vitamin D
supplementation during pregnancy had no effect on the
incidence of adverse effects like preeclampsia, GDM,
preterm birth, small-for-gestational-age infants, and
cesarean section [45]. Nevertheless, these data were re-
trieved from trials conducted on populations living in
the northern latitudes. It cannot be generalized to
countries like Saudi Arabia, where there is enough sun
exposure. Though sartorial parameters like the cultural
practice of complete covering of the body, head and
even face, in addition to the restriction of outdoors ac-
tivities, might counteract this positive effect of the ample
sunlight [24, 52, 53]. It is highly recommended putting
into consideration each population characteristic while
investigating the role of hypovitaminosis D in relation to
pregnancy outcome. Factors such as geographic location
Fig. 2 Correlation between vitamin D levels and pregnancy status. a A weak negative correlation between vitamin D levels and parity (r = −0.07,
p = 0.3). b A significant negative correlation between the vitamin D levels and the fasting levels of oral glucose tolerance test (OGTT) among
females aging more than 35-year-old (r = −0.2, p = 0.03)
Fig. 1 ROC curve analysis of serum Vitamin D and its relation to
normal pregnancy outcome discrimination. AUROC curve: 0.51;
95 % confidence interval (CI): 0.44–0.58; p = 0.8
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and latitude, ethnicity, skin phenotype and individual re-
sponse to UV, age, physical activity and poor diet have
to be interpreted cautiously [8, 51, 53]. Even vitamin D
supplementation should be adjusted in relation to the
population reference baseline, especially in pregnant
women residing in countries with high prevalence of
hypovitaminosis D like Saudi Arabia [51].
Maternal vitamin D levels vary during gestation.
Serum 1,25(OH)D increases normally from the end of
the first trimester and reaches its maximum level in the
third trimester [54]. However, associated increase in
25(OH)D levels could not be identified [55]. Moreover,
Vitamin D action is affected by factors like its metabol-
ism and other hormonal and metabolic pathways [56]. It
can be speculated that factors other than vitamin D can
determine maternal and neonatal outcomes. Further-
more, vitamin D action is also dependent on its inter-
action with its binding protein and its receptor [56]. In
fact, genetic variations (e.g. Vitamin D receptor poly-
morphisms) can be involved in vitamin D metabolism
and in disease susceptibility [57]. Such population differ-
ences could explain the disparity in data published regard-
ing the effect of vitamin D on pregnancy outcomes.
Finally, the increased oxidative stress associated with any
placental dysfunction causes an alteration in the expres-
sion of vitamin D-binding protein and vitamin D recep-
tors [58] that subsequently can alter the vitamin D action.
This study provided novel information about the rela-
tion of vitamin D status and pregnancy outcomes in the
Saudi population. It was conducted on a large sample
size, yet it had some limitations. Data of vitamin D con-
centrations during early pregnancy were not available as
pregnant women were reluctant to follow up in govern-
mental hospitals. Confounders like pre-pregnancy BMI,
lifestyle and physical activity were not investigated. Our
data revealed that vitamin D deficiency has no effect on
the risk of adverse pregnancy and birth outcomes. How-
ever, the study design is of cross-sectional nature; this hin-
dered the confirmation of the causal relationship between
vitamin D levels and history of miscarriage, a common
unfavorable pregnancy outcome reported in this research.
Conclusion
The study underscores the importance of measurement
of serum 25(OH)D within the Saudi population. Never-
theless, hypovitaminosis D showed no relation to ad-
verse pregnancy outcomes in this research. Regardless of
all associations or correlation studies that have been
published, none can give a direct proof of the causality
of vitamin D deficiency in different pregnancy outcomes.
Further interventional and experimental studies must be
conducted to clarify the exact implication of vitamin D
in inducing these adverse effects. In addition, a prospect-
ive study is needed to give stronger evidence on the
suggested correlation between vitamin D and miscarriage.
Although there is a lack of agreement on the need for vita-
min D intake during pregnancy, vitamin supplementation
is still recommended until this dilemma is deciphered.
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